Aspen Pharmacare Holdings Ltd Total Liabilities
Aspen Pharmacare Holdings Ltd total liabilities. Based on the latest financial reports, Aspen Pharmacare Holdings Ltd (APN) has total liabilities worth ZAC46.96 Billion ZAC (≈ $24.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Aspen Pharmacare Holdings Ltd (APN) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Aspen Pharmacare Holdings Ltd (2003–2025)
Total liabilities of Aspen Pharmacare Holdings Ltd from 2003 to 2025. This chart illustrates how Aspen Pharmacare Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Aspen Pharmacare Holdings Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Aspen Pharmacare Holdings Ltd Competitors by Total Liabilities
The table below lists competitors of Aspen Pharmacare Holdings Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aris Mining Corporation
NYSE MKT:ARMN
|
USA | $977.30 Million |
|
Hamilton Lane Inc
NASDAQ:HLNE
|
USA | $844.76 Million |
|
L&K Engineering Co Ltd
TW:6139
|
Taiwan | NT$59.33 Billion |
|
Hanwha Solutions
KO:009830
|
Korea | ₩22.90 Trillion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥3.08 Billion |
|
Harvey Norman Holdings Ltd
AU:HVN
|
Australia | AU$3.82 Billion |
|
MAZDA MOTOR UNSP.ADR/2
F:MZA0
|
Germany | €2.27 Trillion |
|
Baic Bluepark New Energy Technology
SHG:600733
|
China | CN¥28.37 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Aspen Pharmacare Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Aspen Pharmacare Holdings Ltd asset portfolio.
Liquidity & Leverage Metrics
Aspen Pharmacare Holdings Ltd Total Liabilities Ratios Explained
Aspen Pharmacare Holdings Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aspen Pharmacare Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aspen Pharmacare Holdings Ltd (2003–2025)
The table below shows the annual total liabilities of Aspen Pharmacare Holdings Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | ZAC51.00 Billion ≈ $27.10 Million |
-6.07% |
| 2024-06-30 | ZAC54.29 Billion ≈ $28.85 Million |
+13.00% |
| 2023-06-30 | ZAC48.05 Billion ≈ $25.54 Million |
+18.83% |
| 2022-06-30 | ZAC40.43 Billion ≈ $21.49 Million |
-8.23% |
| 2021-06-30 | ZAC44.06 Billion ≈ $23.41 Million |
-31.11% |
| 2020-06-30 | ZAC63.95 Billion ≈ $33.99 Million |
-6.10% |
| 2019-06-30 | ZAC68.10 Billion ≈ $36.19 Million |
-17.69% |
| 2018-06-30 | ZAC82.74 Billion ≈ $43.97 Million |
+13.03% |
| 2017-06-30 | ZAC73.20 Billion ≈ $38.90 Million |
+18.45% |
| 2016-06-30 | ZAC61.80 Billion ≈ $32.84 Million |
+13.90% |
| 2015-06-30 | ZAC54.26 Billion ≈ $28.83 Million |
+1.09% |
| 2014-06-30 | ZAC53.67 Billion ≈ $28.52 Million |
+137.24% |
| 2013-06-30 | ZAC22.62 Billion ≈ $12.02 Million |
+57.98% |
| 2012-06-30 | ZAC14.32 Billion ≈ $7.61 Million |
+6.00% |
| 2011-06-30 | ZAC13.51 Billion ≈ $7.18 Million |
+51.55% |
| 2010-06-30 | ZAC8.91 Billion ≈ $4.74 Million |
+7.94% |
| 2009-06-30 | ZAC8.26 Billion ≈ $4.39 Million |
+9.68% |
| 2008-06-30 | ZAC7.53 Billion ≈ $4.00 Million |
+46.42% |
| 2007-06-30 | ZAC5.14 Billion ≈ $2.73 Million |
+102.17% |
| 2006-06-30 | ZAC2.54 Billion ≈ $1.35 Million |
+25.33% |
| 2005-06-30 | ZAC2.03 Billion ≈ $1.08 Million |
+94.55% |
| 2004-06-30 | ZAC1.04 Billion ≈ $554.39K |
+17.64% |
| 2003-06-30 | ZAC886.73 Million ≈ $471.25K |
-- |
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more